• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本患者中使用放松疗法来减轻化疗的副作用。

Use of relaxation to reduce side effects of chemotherapy in Japanese patients.

作者信息

Arakawa S

机构信息

School of Nursing, Catholic University of America, Washington, D.C.

出版信息

Cancer Nurs. 1995 Feb;18(1):60-6.

PMID:7866978
Abstract

Nausea and vomiting have been recognized as the most distressing side effects of chemotherapy, and are experienced by 66-91% of chemotherapy patients in Japan. Relaxation measures have been used for patients with various other diagnoses, but this technique has never been applied to patients receiving cancer chemotherapy. This pilot study examined the effects of progressive muscle relaxation (PMR) to reduce nausea, vomiting, and anxiety associated with chemotherapy in Japanese patients. Data for eight subjects who were randomly assigned to a treatment group or a control group were analyzed. Both treatment and control groups showed decrease in nausea and vomiting; therefore, the effect of PMR was not verified. However, there was an average decrease of 2.5 points in state-anxiety scores in the treatment group. In addition, some positive effects of PMR were shown by the subjects in the treatment group.

摘要

恶心和呕吐被认为是化疗最令人痛苦的副作用,在日本,66%至91%的化疗患者会出现这些症状。放松措施已用于患有各种其他病症的患者,但该技术从未应用于接受癌症化疗的患者。这项初步研究考察了渐进性肌肉放松(PMR)对减轻日本化疗患者的恶心、呕吐及化疗相关焦虑的效果。对随机分配到治疗组或对照组的8名受试者的数据进行了分析。治疗组和对照组的恶心和呕吐症状均有所减轻;因此,PMR的效果未得到验证。然而,治疗组的状态焦虑评分平均下降了2.5分。此外,治疗组的受试者显示出PMR的一些积极效果。

相似文献

1
Use of relaxation to reduce side effects of chemotherapy in Japanese patients.在日本患者中使用放松疗法来减轻化疗的副作用。
Cancer Nurs. 1995 Feb;18(1):60-6.
2
A pilot study of a relaxation technique for management of nausea and vomiting in patients receiving cancer chemotherapy.一项关于放松技巧对癌症化疗患者恶心呕吐管理作用的初步研究。
Cancer Nurs. 2007 Mar-Apr;30(2):163-7. doi: 10.1097/01.NCC.0000265007.87311.d0.
3
Effects of coping style and relaxation on cancer chemotherapy side effects and emotional responses.应对方式与放松对癌症化疗副作用及情绪反应的影响。
Cancer Nurs. 1990 Oct;13(5):308-15.
4
The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial.渐进性肌肉松弛训练对中国乳腺癌患者化疗所致恶心和呕吐的管理效果:一项随机对照试验。
Support Care Cancer. 2002 Apr;10(3):237-46. doi: 10.1007/s00520-001-0329-9. Epub 2001 Dec 18.
5
Relaxation training for control of nausea and vomiting in patients receiving chemotherapy.放松训练对化疗患者恶心呕吐的控制作用
Cancer Nurs. 1983 Aug;6(4):277-83.
6
Association of chemotherapy related nausea and vomiting with pretreatment anxiety.
Oncol Nurs Forum. 1986 Jan-Feb;13(1):41-7.
7
Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.比较两种剂量静脉注射格拉司琼(1毫克和3毫克)用于癌症患者急性化疗引起的恶心和呕吐的随机对照研究:一项非劣效性试验。
Jpn J Clin Oncol. 2009 Jul;39(7):443-8. doi: 10.1093/jjco/hyp036. Epub 2009 Apr 24.
8
The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.口服NK(1)拮抗剂阿瑞匹坦与标准止吐药联合使用,在多周期基于顺铂的化疗中可预防恶心和呕吐:两项随机、安慰剂对照的III期临床试验的联合分析。
Eur J Cancer. 2004 Feb;40(3):403-10.
9
Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.托烷司琼(呕必停)单药及与地塞米松联合用于预防化疗引起的呕吐:北欧的经验。
Semin Oncol. 1994 Oct;21(5 Suppl 9):20-6.
10
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.尽管进行了止吐治疗,但在接受高度和中度致吐性化疗后,延迟性恶心和呕吐仍会持续降低患者的生活质量。
J Clin Oncol. 2006 Sep 20;24(27):4472-8. doi: 10.1200/JCO.2006.05.6382.